Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses
Luis M Franco, Manasi Gadkari, Katherine N Howe, Jing Sun, Lela Kardava, Parag Kumar, Sangeeta Kumari, Zonghui Hu, Iain D C Fraser, Susan Moir, John S Tsang, Ronald N Germain, Luis M Franco, Manasi Gadkari, Katherine N Howe, Jing Sun, Lela Kardava, Parag Kumar, Sangeeta Kumari, Zonghui Hu, Iain D C Fraser, Susan Moir, John S Tsang, Ronald N Germain
Abstract
Glucocorticoids remain the most widely used immunosuppressive and anti-inflammatory drugs, yet substantial gaps exist in our understanding of glucocorticoid-mediated immunoregulation. To address this, we generated a pathway-level map of the transcriptional effects of glucocorticoids on nine primary human cell types. This analysis revealed that the response to glucocorticoids is highly cell type dependent, in terms of the individual genes and pathways affected, as well as the magnitude and direction of transcriptional regulation. Based on these data and given their importance in autoimmunity, we conducted functional studies with B cells. We found that glucocorticoids impair upstream B cell receptor and Toll-like receptor 7 signaling, reduce transcriptional output from the three immunoglobulin loci, and promote significant up-regulation of the genes encoding the immunomodulatory cytokine IL-10 and the terminal-differentiation factor BLIMP-1. These findings provide new mechanistic understanding of glucocorticoid action and emphasize the multifactorial, cell-specific effects of these drugs, with potential implications for designing more selective immunoregulatory therapies.
This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.
Figures
References
- Akdis C.A., Blesken T., Akdis M., Alkan S.S., Heusser C.H., and Blaser K.. 1997. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur. J. Immunol. 27:2351–2357. 10.1002/eji.1830270933
- Altonsy M.O., Sasse S.K., Phang T.L., and Gerber A.N.. 2014. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation. J. Biol. Chem. 289:8231–8239. 10.1074/jbc.M113.545178
- Bankó Z., Pozsgay J., Szili D., Tóth M., Gáti T., Nagy G., Rojkovich B., and Sármay G.. 2017. Induction and differentiation of IL-10-producing regulatory B cells from healthy blood donors and rheumatoid arthritis patients. J. Immunol. 198:1512–1520. 10.4049/jimmunol.1600218
- Bartholome B., Spies C.M., Gaber T., Schuchmann S., Berki T., Kunkel D., Bienert M., Radbruch A., Burmester G.R., Lauster R., et al. . 2004. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J. 18:70–80. 10.1096/fj.03-0328com
- Benjamini Y., and Hochberg Y.. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57:289–300.
- Bolli N., Biancon G., Moarii M., Gimondi S., Li Y., de Philippis C., Maura F., Sathiaseelan V., Tai Y.T., Mudie L., et al. . 2018. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups. Leukemia. 32:2604–2616. 10.1038/s41375-018-0037-9
- Burwick N., and Sharma S.. 2018. Glucocorticoids in multiple myeloma: past, present, and future. Ann. Hematol. 10.1007/s00277-018-3465-8
- Buttgereit F., and Scheffold A.. 2002. Rapid glucocorticoid effects on immune cells. Steroids. 67:529–534. 10.1016/S0039-128X(01)00171-4
- Buttgereit F., Brand M.D., and Müller M.. 1993. Effects of methylprednisolone on the energy metabolism of quiescent and ConA-stimulated thymocytes of the rat. Biosci. Rep. 13:41–52. 10.1007/BF01138177
- Cain D.W., and Cidlowski J.A.. 2017. Immune regulation by glucocorticoids. Nat. Rev. Immunol. 17:233–247. 10.1038/nri.2017.1
- Chaganti S., Illidge T., Barrington S., Mckay P., Linton K., Cwynarski K., McMillan A., Davies A., Stern S., and Peggs K.. British Committee for Standards in Haematology . 2016. Guidelines for the management of diffuse large B-cell lymphoma. Br. J. Haematol. 174:43–56. 10.1111/bjh.14136
- Croxtall J.D., Choudhury Q., and Flower R.J.. 2000. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br. J. Pharmacol. 130:289–298. 10.1038/sj.bjp.0703272
- Dale D.C., Fauci A.S., Guerry D I.V., and Wolff S.M.. 1975. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J. Clin. Invest. 56:808–813. 10.1172/JCI108159
- Deane J.A., Pisitkun P., Barrett R.S., Feigenbaum L., Town T., Ward J.M., Flavell R.A., and Bolland S.. 2007. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 27:801–810. 10.1016/j.immuni.2007.09.009
- Derendorf H., Möllmann H., Krieg M., Tunn S., Möllmann C., Barth J., and Röthig H.J.. 1991. Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers. Pharm. Res. 8:263–268. 10.1023/A:1015864709082
- Díaz-Jiménez D., Núñez L., De la Fuente M., Dubois-Camacho K., Sepúlveda H., Montecino M., Torres-Riquelme A., García-González P., Chnaiderman J., Vossenkamper A., et al. . 2017. A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis. Sci. Rep. 7:10180 10.1038/s41598-017-10465-0
- Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., and Gingeras T.R.. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 29:15–21. 10.1093/bioinformatics/bts635
- Dunleavy K., Erdmann T., and Lenz G.. 2018. Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma. Cancer Treat. Rev. 65:41–46. 10.1016/j.ctrv.2018.01.002
- Fairhurst A.M., Hwang S.H., Wang A., Tian X.H., Boudreaux C., Zhou X.J., Casco J., Li Q.Z., Connolly J.E., and Wakeland E.K.. 2008. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur. J. Immunol. 38:1971–1978. 10.1002/eji.200838138
- Fearon D.T., and Carroll M.C.. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:393–422. 10.1146/annurev.immunol.18.1.393
- Frankenberger M., Häussinger K., and Ziegler-Heitbrock L.. 2005. Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophages. Int. Immunopharmacol. 5:289–299. 10.1016/j.intimp.2004.09.033
- Funder J.W., Pearce P.T., Smith R., and Smith A.I.. 1988. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 242:583–585. 10.1126/science.2845584
- Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., O’Shea J.J., Chrousos G.P., and Bornstein S.R.. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16:61–71. 10.1096/fj.01-0245com
- Gametchu B. 1987. Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis. Science. 236:456–461. 10.1126/science.3563523
- Gametchu B., Watson C.S., and Wu S.. 1993. Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB J. 7:1283–1292. 10.1096/fasebj.7.13.8405814
- García-Ortiz H., Velázquez-Cruz R., Espinosa-Rosales F., Jiménez-Morales S., Baca V., and Orozco L.. 2010. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann. Rheum. Dis. 69:1861–1865. 10.1136/ard.2009.124313
- Gharib A., Louis A.G., Agrawal S., and Gupta S.. 2015. Syndrome of selective IgM deficiency with severe T cell deficiency associated with disseminated cutaneous mycobacterium avium intracellulaire infection. Am. J. Clin. Exp. Immunol. 4:15–27.
- Grøntved L., John S., Baek S., Liu Y., Buckley J.R., Vinson C., Aguilera G., and Hager G.L.. 2013. C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J. 32:1568–1583. 10.1038/emboj.2013.106
- Guiducci C., Gong M., Xu Z., Gill M., Chaussabel D., Meeker T., Chan J.H., Wright T., Punaro M., Bolland S., et al. . 2010. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature. 465:937–941. 10.1038/nature09102
- Harrow J., Frankish A., Gonzalez J.M., Tapanari E., Diekhans M., Kokocinski F., Aken B.L., Barrell D., Zadissa A., Searle S., et al. . 2012. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22:1760–1774. 10.1101/gr.135350.111
- Hench P.S., Kendall E.C., et al. . 1949. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc. Staff Meet. Mayo Clin. 24:181–197.
- Herold M.J., McPherson K.G., and Reichardt H.M.. 2006. Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 63:60–72. 10.1007/s00018-005-5390-y
- Hills A.G., Forsham P.H., and Finch C.A.. 1948. Changes in circulating leukocytes induced by the administration of pituitary adrenocorticotrophic hormone in man. Blood. 3:755–768.
- Hojo M., Iikura M., Hirano S., Sugiyama H., Kobayashi N., and Kudo K.. 2012. Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy. Respirology. 17:185–190. 10.1111/j.1440-1843.2011.02076.x
- Hudson W.H., Youn C., and Ortlund E.A.. 2013. The structural basis of direct glucocorticoid-mediated transrepression. Nat. Struct. Mol. Biol. 20:53–58. 10.1038/nsmb.2456
- Imasato A., Desbois-Mouthon C., Han J., Kai H., Cato A.C., Akira S., and Li J.D.. 2002. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J. Biol. Chem. 277:47444–47450. 10.1074/jbc.M208140200
- John K., Marino J.S., Sanchez E.R., and Hinds T.D. Jr. 2016. The glucocorticoid receptor: cause of or cure for obesity? Am. J. Physiol. Endocrinol. Metab. 310:E249–E257. 10.1152/ajpendo.00478.2015
- John S., Sabo P.J., Thurman R.E., Sung M.H., Biddie S.C., Johnson T.A., Hager G.L., and Stamatoyannopoulos J.A.. 2011. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43:264–268. 10.1038/ng.759
- Kim K.D., Choe Y.K., Choe I.S., and Lim J.S.. 2001. Inhibition of glucocorticoid-mediated, caspase-independent dendritic cell death by CD40 activation. J. Leukoc. Biol. 69:426–434.
- Klaustermeyer W.B., Gianos M.E., Kurohara M.L., Dao H.T., and Heiner D.C.. 1992. IgG subclass deficiency associated with corticosteroids in obstructive lung disease. Chest. 102:1137–1142. 10.1378/chest.102.4.1137
- Liao Y., Smyth G.K., and Shi W.. 2014. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 30:923–930. 10.1093/bioinformatics/btt656
- Love M.I., Huber W., and Anders S.. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:550 10.1186/s13059-014-0550-8
- Love M.I., Huska M.R., Jurk M., Schöpflin R., Starick S.R., Schwahn K., Cooper S.B., Yamamoto K.R., Thomas-Chollier M., Vingron M., and Meijsing S.H.. 2017. Role of the chromatin landscape and sequence in determining cell type-specific genomic glucocorticoid receptor binding and gene regulation. Nucleic Acids Res. 45:1805–1819. 10.1093/nar/gkw1163
- Lu H., Dietsch G.N., Matthews M.A., Yang Y., Ghanekar S., Inokuma M., Suni M., Maino V.C., Henderson K.E., Howbert J.J., et al. . 2012. VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. Clin. Cancer Res. 18:499–509. 10.1158/1078-0432.CCR-11-1625
- Lu N.Z., Collins J.B., Grissom S.F., and Cidlowski J.A.. 2007. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol. Cell. Biol. 27:7143–7160. 10.1128/MCB.00253-07
- Martin M.2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17:10–12.
- Matsuuchi L., Gold M.R., Travis A., Grosschedl R., DeFranco A.L., and Kelly R.B.. 1992. The membrane IgM-associated proteins MB-1 and Ig-beta are sufficient to promote surface expression of a partially functional B-cell antigen receptor in a nonlymphoid cell line. Proc. Natl. Acad. Sci. USA. 89:3404–3408. 10.1073/pnas.89.8.3404
- Mauri C., and Menon M.. 2017. Human regulatory B cells in health and disease: therapeutic potential. J. Clin. Invest. 127:772–779. 10.1172/JCI85113
- Miyata M., Lee J.Y., Susuki-Miyata S., Wang W.Y., Xu H., Kai H., Kobayashi K.S., Flavell R.A., and Li J.D.. 2015. Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M. Nat. Commun. 6:6062 10.1038/ncomms7062
- Möllmann H., Rohdewald P., Barth J., Verho M., and Derendorf H.. 1989. Pharmacokinetics and dose linearity testing of methylprednisolone phosphate. Biopharm. Drug Dispos. 10:453–464. 10.1002/bdd.2510100504
- Mozo L., Suárez A., and Gutiérrez C.. 2004. Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin. Exp. Allergy. 34:406–412. 10.1111/j.1365-2222.2004.01824.x
- National Guideline Alliance 2016. Non-Hodgkin’s lymphoma: Diagnosis and management. In Non-Hodgkin’s Lymphoma: Diagnosis and Management. National Institute for Health and Care Excellence, London.
- Olnes M.J., Kotliarov Y., Biancotto A., Cheung F., Chen J., Shi R., Zhou H., Wang E., Tsang J.S., and Nussenblatt R.. CHI Consortium . 2016. Effects of systemically administered hydrocortisone on the human immunome. Sci. Rep. 6:23002 10.1038/srep23002
- Pape K.A., Taylor J.J., Maul R.W., Gearhart P.J., and Jenkins M.K.. 2011. Different B cell populations mediate early and late memory during an endogenous immune response. Science. 331:1203–1207. 10.1126/science.1201730
- Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., and Bolland S.. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 312:1669–1672. 10.1126/science.1124978
- Posey W.C., Nelson H.S., Branch B., and Pearlman D.S.. 1978. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J. Allergy Clin. Immunol. 62:340–348. 10.1016/0091-6749(78)90134-3
- Rao N.A., McCalman M.T., Moulos P., Francoijs K.J., Chatziioannou A., Kolisis F.N., Alexis M.N., Mitsiou D.J., and Stunnenberg H.G.. 2011. Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Res. 21:1404–1416. 10.1101/gr.118042.110
- Rapicavoli N.A., Qu K., Zhang J., Mikhail M., Laberge R.M., and Chang H.Y.. 2013. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife. 2:e00762 10.7554/eLife.00762
- Ratman D., Vanden Berghe W., Dejager L., Libert C., Tavernier J., Beck I.M., and De Bosscher K.. 2013. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Mol. Cell. Endocrinol. 380:41–54. 10.1016/j.mce.2012.12.014
- Rawlings D.J., Schwartz M.A., Jackson S.W., and Meyer-Bahlburg A.. 2012. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 12:282–294. 10.1038/nri3190
- R Development Core Team 2009. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. .
- Reddy T.E., Gertz J., Crawford G.E., Garabedian M.J., and Myers R.M.. 2012. The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes. Mol. Cell. Biol. 32:3756–3767. 10.1128/MCB.00062-12
- Sacta M.A., Chinenov Y., and Rogatsky I.. 2016. Glucocorticoid signaling: An update from a genomic perspective. Annu. Rev. Physiol. 78:155–180. 10.1146/annurev-physiol-021115-105323
- Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin A.S. Jr. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 270:283–286. 10.1126/science.270.5234.283
- Schmid D., Burmester G.R., Tripmacher R., Kuhnke A., and Buttgereit F.. 2000. Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states. Biosci. Rep. 20:289–302. 10.1023/A:1026445108136
- Schmittgen T.D., and Livak K.J.. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101–1108. 10.1038/nprot.2008.73
- Shukla N.M., Malladi S.S., Mutz C.A., Balakrishna R., and David S.A.. 2010. Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues. J. Med. Chem. 53:4450–4465. 10.1021/jm100358c
- Smyth G.K. 2005. Limma: Linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Gentleman R., V. Carey, Dudoit S., Irizarry R., and Huber W., editors. Springer, New York: 397–420. 10.1007/0-387-29362-0_23
- Souyris M., Cenac C., Azar P., Daviaud D., Canivet A., Grunenwald S., Pienkowski C., Chaumeil J., Mejía J.E., and Guéry J.C.. 2018. TLR7 escapes X chromosome inactivation in immune cells. Sci. Immunol. 3:eaap8855 10.1126/sciimmunol.aap8855
- Stahn C., and Buttgereit F.. 2008. Genomic and nongenomic effects of glucocorticoids. Nat. Clin. Pract. Rheumatol. 4:525–533. 10.1038/ncprheum0898
- Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., and Mesirov J.P.. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102:15545–15550. 10.1073/pnas.0506580102
- Surjit M., Ganti K.P., Mukherji A., Ye T., Hua G., Metzger D., Li M., and Chambon P.. 2011. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell. 145:224–241. 10.1016/j.cell.2011.03.027
- Suthers A.N., and Sarantopoulos S.. 2017. TLR7/TLR9- and B cell receptor-signaling crosstalk: Promotion of potentially dangerous B cells. Front. Immunol. 8:775 10.3389/fimmu.2017.00775
- Venkitaraman A.R., Williams G.T., Dariavach P., and Neuberger M.S.. 1991. The B-cell antigen receptor of the five immunoglobulin classes. Nature. 352:777–781. 10.1038/352777a0
- Vockley C.M., D’Ippolito A.M., McDowell I.C., Majoros W.H., Safi A., Song L., Crawford G.E., and Reddy T.E.. 2016. Direct GR binding sites potentiate clusters of TF binding across the human genome. Cell. 166:1269–1281.e19. 10.1016/j.cell.2016.07.049
- Weinstein R.S., Jilka R.L., Parfitt A.M., and Manolagas S.C.. 1998. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102:274–282. 10.1172/JCI2799
- Yu Y.H., and Lin K.I.. 2016. Factors that regulate the generation of antibody-secreting plasma cells. Adv. Immunol. 131:61–99. 10.1016/bs.ai.2016.03.001
Source: PubMed